IBCSG 22-00 Maintenance Chemotherapy in Hormone Non-Responsive Breast Cancer

Phase 3

Completed

• Conditions: Adjuvant Breast Cancer; Cancer - Breast

• Registration Number: ACTRN12605000355673
• Lead Sponsor: Australia and New Zealand Breast Cancer Trials Group

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 1080

Inclusion Criteria

Premenopausal or postmenopausal patients with histologically proven, receptor-negative primary breast cancer who are in adequate health to begin or continue with induction chemotherapy, have completed baseline Quality of Life forms, are geographically accessible for follow-up and have signed written informed consent.

Exclusion Criteria

Patients with bilateral disease, positive margins in the resected tumour specimen, previous or concomitant malignancy, patients who have received prior therapy for breast cancer, or who have non-malignant systemic diseases that would prevent them from undergoing any trial treatment options, or who are pregnant or lactating within 6 months of diagnosis.

Study & Design

• Study Type: Interventional
• Study Design: Not specified